Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study

per Ohnishi, Kazunori, Nakaseko, Chiaki, Takeuchi, Jin, Fujisawa, Shin, Nagai, Tadashi, Yamazaki, Hirohito, Tauchi, Tetsuzo, Imai, Kiyotoshi, Mori, Naoki, Yagasaki, Fumiharu, Maeda, Yasuhiro, Usui, Noriko, Miyazaki, Yasushi, Miyamura, Koichi, Kiyoi, Hitoshi, Ohtake, Shigeki, Naoe, Tomoki
Publicat a Cancer Sci (2012)

Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation

per Nicolini, Franck E., Mauro, Michael J., Martinelli, Giovanni, Kim, Dong-Wook, Soverini, Simona, Müller, Martin C., Hochhaus, Andreas, Cortes, Jorge, Chuah, Charles, Dufva, Inge H., Apperley, Jane F., Yagasaki, Fumiharu, Pearson, Jay D., Peter, Senaka, Sanz Rodriguez, Cesar, Preudhomme, Claude, Giles, Francis, Goldman, John M., Zhou, Wei
Publicat a Blood (2009)